TowerView LLC’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-210,000
| Closed | -$181K | – | 25 |
|
|
2019
Q4 | $181K | Sell |
210,000
-165,000
| -44% | -$127K | 0.12% | 18 |
|
|
2019
Q3 | $210K | Sell |
375,000
-104,698
| -22% | -$56.3K | 0.13% | 20 |
|
|
2019
Q2 | $249K | Hold |
479,698
| – | – | 0.14% | 19 |
|
|
2019
Q1 | $216K | Hold |
479,698
| – | – | 0.12% | 18 |
|
|
2018
Q4 | $230K | Hold |
479,698
| – | – | 0.13% | 16 |
|
|
2018
Q3 | $254K | Sell |
479,698
-20,302
| -4% | -$10.9K | 0.12% | 17 |
|
|
2018
Q2 | $250K | Sell |
500,000
-100,000
| -17% | -$46.6K | 0.12% | 21 |
|
|
2018
Q1 | $254K | Hold |
600,000
| – | – | 0.12% | 21 |
|
|
2017
Q4 | $228K | Hold |
600,000
| – | – | 0.11% | 21 |
|
|
2017
Q3 | $216K | Hold |
600,000
| – | – | 0.11% | 18 |
|
|
2017
Q2 | $228K | Hold |
600,000
| – | – | 0.12% | 23 |
|
|
2017
Q1 | $270K | Sell |
600,000
-148,500
| -20% | -$65.2K | 0.13% | 24 |
|
|
2016
Q4 | $284K | Sell |
748,500
-401,500
| -35% | -$136K | 0.12% | 25 |
|
|
2016
Q3 | $307K | Sell |
1,150,000
-50,000
| -4% | -$12.7K | 0.14% | 23 |
|
|
2016
Q2 | $288K | Sell |
1,200,000
-100,000
| -8% | -$17.2K | 0.13% | 26 |
|
|
2016
Q1 | $148K | Buy |
1,300,000
+297,824
| +30% | +$32.3K | 0.07% | 29 |
|
|
2015
Q4 | $113K | Buy |
1,002,176
+702,176
| +234% | +$99.1K | 0.06% | 29 |
|
|
2015
Q3 | $57K | Sell |
300,000
-85,000
| -22% | -$28.9K | 0.03% | 30 |
|
|
2015
Q2 | $270K | Sell |
385,000
-10,000
| -3% | -$6.92K | 0.13% | 24 |
|
|
2015
Q1 | $268K | Hold |
395,000
| – | – | 0.12% | 22 |
|
|
2014
Q4 | $312K | Sell |
395,000
-5,000
| -1% | -$3.42K | 0.14% | 20 |
|
|
2014
Q3 | $186K | Hold |
400,000
| – | – | 0.11% | 20 |
|
|
2014
Q2 | $200K | Sell |
400,000
-50,000
| -11% | -$24.2K | 0.1% | 20 |
|
|
2014
Q1 | $140K | Sell |
450,000
-50,000
| -10% | -$18.6K | 0.06% | 19 |
|
|
2013
Q4 | $170K | Buy |
500,000
+280,000
| +127% | +$338K | 0.08% | 18 |
|
|
2013
Q3 | $444K | Sell |
220,000
-87,914
| -29% | -$167K | 0.22% | 16 |
|
|
2013
Q2 | $585K | Buy |
+307,914
| New | +$541K | 0.23% | 18 |
|
TowerView LLC's GCVRZ Position: Q1 2020 in Review
TowerView LLC sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 210,000 shares — an estimated $181K sold.
TowerView LLC first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $585K in Q2 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- TowerView LLC reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- TowerView LLC sold 210,000 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $181K.
- TowerView LLC first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- TowerView LLC's Sanofi Contingent Value Rights position peaked at $585K in Q2 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on TowerView LLC's 13F filing for Q1 2020, filed 30 Apr 2020.